Zoom in on neurodegeneration by Bu, Guojun et al.
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
Molecular Neurodegeneration
Open Access Editorial
Zoom in on neurodegeneration
Guojun Bu*1, Huaxi Xu2 and Todd E Golde3
Address: 1Departments of Pediatrics, and Cell Biology and Physiology, Washington University School of Medicine, St Louis, MO 63110, USA, 
2Center for Neuroscience and Aging, The Burnham Institute, La Jolla, California 92037, USA and 3Department of Neuroscience, Mayo Clinic, Mayo 
Clinic College of Medicine, Jacksonville, Florida 32224, USA
Email: Guojun Bu* - bu@wustl.edu; Huaxi Xu - xuh@burnham.org; Todd E Golde - Golde.Todd@mayo.edu
* Corresponding author    
Abstract
Despite the existence of several scientific journals that publish research papers and reviews related
to neurodegenerative diseases, a journal specifically devoted to the molecular and cellular aspects
of disease mechanisms is lacking. Molecular Neurodegeneration is an open-access, peer-reviewed,
online journal created to publish original research articles that address i) the mechanisms of
neurodegeneration at the cellular, subcellular and molecular levels and ii) potential therapeutic
interventions for neurodegenerative diseases. Through publication of reviews, editorial
commentaries, and meeting reports, Molecular Neurodegeneration will also provide a forum to
enhance the exchange of ideas and promote debate that is essential for scientific progress.
Molecular Neurodegeneration will enable scientists to rapidly communicate their important research
discoveries to their colleagues around the world.
We are proud to introduce you to a new home for neuro-
degeneration research, Molecular Neurodegeneration.
Through the open-access format we plan to bring you the
most timely and exciting research focusing on the molec-
ular and cellular mechanisms underlying neurodegenera-
tive disease processes and on potential therapeutic
interventions for these devastating diseases. Molecular
Neurodegeneration will also provide a forum to discuss and
review the current research and foster creative thinking in
this exciting field.
The increased prevalence of certain age-associated neuro-
degenerative diseases is largely attributable to the increase
in average lifespan among individuals who live in indus-
trialized nations. From a patient perspective, diseases such
as Alzheimer's, Parkinson's or amyotrophic lateral sclero-
sis are feared because of their slow and progressive nature
and because there are no effective treatments or cures for
these diseases. The economic and social burden of neuro-
degenerative diseases is huge and growing all too rapidly.
We have made significant progress with respect to under-
standing certain aspects of neurodegenerative diseases.
However, compared to our understanding of other
human diseases such as cancer and cardiovascular disor-
ders, our knowledge on the mechanisms of neurodegener-
ation is still in its infancy. Indeed, for most
neurodegenerative diseases, we can only guess as to why
neurons ultimately die.
Most existing scientific journals that publish research
papers related to neurodegenerative diseases focus on the
genetic epidemiology and pathological aspects of these
diseases. Molecular Neurodegeneration will uniquely focus
on the molecular and cellular aspects of the disease mech-
anisms, identification of potential therapeutic targets, and
preclinical studies evaluating potential therapeutic inter-
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ventions in model systems. Studies of the physiological
and pathophysiological functions of cellular proteins con-
tributing to neurodegeneration are strongly encouraged.
We hope this focus will be particularly attractive to neuro-
degenerative disease researchers whose interests are at the
molecular, subcellular and cellular levels as well as those
who are trying to develop and evaluate novel "target-
based" therapies for these diseases.
The majority of published manuscripts will be research
articles and reviews. However, editorials, short reports,
commentaries, meeting reports, and articles concerning
methodology will also be considered. Each manuscript
will be peer reviewed to ensure that the highest standards
are maintained. Once accepted, papers will be immedi-
ately published online and will be listed in PubMed.
An important feature of Molecular Neurodegeneration is the
open-access format. Traditional journals are often access-
restricted and open only to those universities, research
institutes, and individuals who can afford the high fees for
electronic access. We hope that the open-access format
will be attractive to scientists around the world because of
its broad readership. From an editorial perspective we will
strive to ensure that manuscripts are reviewed in both a
fair and timely fashion.
The debut of Molecular Neurodegeneration would not have
been possible without the strong support of many scien-
tists who are at the forefront of research in neurodegener-
ation. Molecular Neurodegeneration has a strong editorial
board with a wide range of expertise in different neurode-
generative diseases and different approaches to disease
mechanisms. Members of Molecular Neurodegeneration's
editorial board are committed to support of the journal by
helping to identify important and interesting research
manuscripts, serving as reviewers, and contributing their
own work to the journal. Our goal is for Molecular Neuro-
degeneration to publish novel findings that can advance
the field of neurodegeneration research. We hope for
enthusiastic support from scientists around the world and
welcome suggestions that will make Molecular Neurode-
generation an important resource in this critical field.
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